Treatment of mice with a ?friendly? bacteria, normally found in the soil, altered their behavior in a way similar to that produced by antidepressant drugs, reports research published in the latest issue of Neuroscience.
The testosterone levels of healthy men decline as they get older. As sleep quality and quantity typically decrease with age, objectively measured differences in the amount of sleep a healthy older man gets can affect his level of testosterone in the morning, according to a study published in the April 1st issue of the journal SLEEP.
Protein degradation and malfunction is a major cause of ageing and can be the result of attacks on proteins by other molecules. One of these processes, called glycation, involves the spontaneous attack by sugars on proteins.
The sixth meeting of the ICCDE – International Commission for the Certification of Dracunculiasis (guinea-worm disease) Eradication – was held 5 to 7 March at WHO headquarters in Geneva.
The next time you are struggling to carry your bags home from the supermarket just remember that this could, in fact, be the reason you are able to walk upright on two legs at all! How we have evolved to walk on two legs remains a fundamental but, as yet, unresolved question for scientists.
By recognizing sugars, a technique developed by University of Michigan analytical chemist Kristina Hakansson sets the stage for new cancer diagnosis and treatment options.
The U.S. Food and Drug Administration (FDA) licensed Ceprotin, the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder.
Members of the Confederation of Indian Industry would spend around Rs 100 crore in setting up 100 anti-retroviral treatment (ART) centres throughout the country for free treatment of HIV/AIDS patients.
How is virus as for example HIV and bird flu able to make the cells within a human body work for the purpose of the virus? Researchers at the University of Copenhagen shed new light on this question.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.